Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms
Author:
|
Kampa-Schittenhelm, Kerstin Maria; Heinrich, Michael Charles; Akmut, Figen; Doehner, Hartmut; Doehner, Konstanze; Schittenhelm, Marcus Matthias
|
Tübinger Autor(en):
|
|
Published in:
|
Molecular Cancer
(2013), Bd.
12,
Article 19
|
Verlagsangabe:
|
Biomed Central Ltd
|
Language:
|
English
|
Full text:
|
http://dx.doi.org/10.1186/1476-4598-12-19
|
ISSN:
|
1476-4598
|
DDC Classifikation:
|
570 - Life sciences; biology 610 - Medicine and health
|
Dokumentart:
|
Article
|
Show full item record
|